Read the May 2003 interview with with Dr. von Eschenbach about his challenge goal of eliminating suffering and death due to cancer by 2015.
- Progress Shown in Death Rates From Four Leading Cancers
The NCI's Report to the Nation concludes that further reductions in cancer can be achieved but will require strong federal, state, local, and private partnerships to apply evidence-based cancer control measures that reach all segments of the population.
Read Dr. von Eschenbach's Director's Update on the Report to the Nation: Status of Cancer in the United States: New Data Points and Opportunities for Improvement
- Cure for What Ails EU
Although most Europeans believe the "private" U.S. healthcare system is a disaster, while European systems, being "public," are fundamentally better, European policymakers are looking to the U.S. for guidance on how to cut health costs without enraging consumers/taxpayers. (from Tech Central Station)
What's New in Myeloma Research:
- Phenylarsonic acid compounds with broad-spectrum and potent cytotoxic activity against human cancer cells.
Uckun FM, D'Cruz OJ, Liu XP, Narla RK.
Results from a preclinical study of the agent at Parker Hughes Cancer Center demonstrated that it caused apoptotic death to testicular, ovarian, multiple myeloma and acute lymphoblastic leukemia cells.
- Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination.
Zhou P, Zhang Y, Martinez C, Kalakonda N, Nimer SD, IMF Scientific Advisor Comenzo RL.
A phase 2 trial of intravenous melphalan and granulocyte colony-stimulating factor (G-CSF) for mobilization was performed.
- Novartis receives "approvable" letter from FDA for updated Zometa label.
They want to to include data about the drug's long-term impact in treating cancer-related bone complications such as fractures and spinal-cord compression. (from Yahoo Finance)
- Development of monoclonal antibody 1D09C3 advances; human trials planned for '04
Results from a number of in vivo studies with 1D09C3 have shown promising and consistent antitumor efficacy in various xenotransplant models, including non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and hairy cell leukemia.
(from Factiva and GPC Biotech Press Release)
- Intermediate dose thalidomide (200 mg daily) has comparable efficacy and less toxicity than higher doses in relapsed multiple myeloma.
Wechalekar AD, Chen CI, Sutton D, Reece D, Voralia M, Stewart AK.
Thalidomide 200 mg daily with no dose escalation appears as effective and better tolerated than escalated doses for relapsed myeloma patients.
What's New in Clinical Trials:
If you would like to browse trials currently open for enrollment, visit the Clinical Trials page of the IMF web site. Among the links, you will find CenterWatch and EmergingMed. The IMF has entered into partnerships with them to assist you in matching trials to your particular patient profile (i.e., stage of disease, previous treatment, how well you are able to carry out the activities of daily living, etc.) and by doing so, increase your chances of being eligible. You can also learn more about clinical trials by reviewing materials from the National Cancer Institute.
Upcoming Seminars and Conferences:
- Torino Patient & Family Seminar
September 12, 2003
- Paris Patient & Family Seminar
September 19, 2003
- Heidelberg Patient & Family Seminar
September 26-28, 2003
- Philadelphia Patient & Family Interactive Seminar
October 17-18 2003
- Tokyo Patient & Family Seminar
November 2, 2003
- Dallas Patient & Family Interactive Seminar
Baylor University Medical Center
November 7-8, 2003
- IVth International Conference on Cancer-Induced Bone Diseases
San Antonio, Texas
December 7-9, 2003
Put on by the Paget Foundation, conference will cover the spectrum of bone metastases caused by breast cancer, prostate cancer, and osteolyic lesions due to myeloma. IMF Board Member Gregory R. Mundy, MD is Conference Chair.
FUNdraising Made Easy
You know you want to do something, but deciding on what to do can be confusing. The IMF can help. This year, our members really rallied 'round the cause, picked up the gauntlet, and raised a lot of money for myeloma research and programs.
We are already getting calls from new members who want to join in the effort and hold an event in 2004. Suzanne Battaglia is waiting for your call. She is here to help you plan and execute your event, so please write, call or email (SBattaglia@myeloma.org) so that you can get on our Calendar of Events!
See what you can do in your community to help further the goal of finding the cure!
- Fiesta for a Cure!
November 16, 2003
Join us for authentic Mexican food, music, margaritas, a chance to make a significant contribution to Bank on a Cure® and the opportunity to win great prizes, including a grand prize of $10,000.
- Ribbon of Hope Making A World of Difference Anniversary Gala
October 4, 2003
Paul Allen's Experience Music Project Museum in Seattle, WA
The evening promises to be the best ever, both creatively and financially! The EMP is Seattle's most unique architectural wonder. The Frank O. Gehry-designed building houses a new interactive museum that combines performance space, technology and revolutionary architecture in a facility created to celebrate the heritage and anticipate the future of American popular music.
- GTC Telecom is reaching out on behalf of the IMF with a wonderful new way for you to help fight myeloma while saving yourself money at the same time!
By signing up for the new IMF Long Distance Plan, 10% of what you spend on your long distance calls every month will be directly donated to the International Myeloma Foundation. This fantastic long distance plan offers you savings of up to 40% or more over what you may currently be paying! Click on the link to find out more.
- The Catlett Card Series
The Catlett Cards are designed by Irma Catlett in memory of her husband Lou. The stunning pictures on these cards chronicle their travels together and honor Lou and the life they shared. Blank on the inside, they are perfect for thank-you's, birthdays, anniversaries, and just general correspondence. All proceeds go to support the programs of the IMF.
- IMFers Esther and Herman Adler, of Adler & Company Jewelers in Los Angeles are continuing their generous offer to help the IMF. Buy beautiful jewelry at wholesale prices andif you tell them you are an IMFer-a portion of the proceeds will be donated to the IMF.
Items of Interest:
- BANK ON A CURE®
BANK ON A CURE is an innovative and powerful concept designed to establish a method to find new treatments for multiple myeloma and other related diseases as well as the possibility of new cures, while customizing care for current patients.
- Myeloma Matrix
The Myeloma Matrix provides updated information about drugs beginning with pre-clinical developments and tracks drugs as they proceed through Phases I III of clinical trials, drugs that have been FDA approved, and information on trials that are being conducted by NCI- sponsored cooperative groups as well as other myeloma study groups. The online version is updated regularly. If you would like to have a printed copy, call the toll-free hotline (800) 452-2873.
- International Prognostic Index
The International Myeloma Foundation is proud to sponsor the International Prognostic Index (IPI) Classification for Multiple Myeloma. Nearly twenty myeloma institutions from around the world are collaborating to create an updated staging system for multiple myeloma.
- NexCura Cancer Profiler
The Cancer Profiler is a free service (no hidden fees or charges). Its tools provide you with information specific to your cancer diagnosis to help you make more informed treatment decisions along with your physician.
- Expert Opinions on Multiple Myeloma
A multimedia, CME-accredited program for physicians with the chance to see world-renowned myeloma specialists sharing their knowledge, discussing treatment choices, and comparing their perspectives on controversial issues in multiple myeloma and related diseases.
An exciting way for myeloma patients to get involved at patient seminars.
- Myeloma At The Movies
It has been our goal to bring our Patient & Family Seminars to people around the country who might not be able to attend an actual meeting, so we have set up a video lending library.
- HealthTalk's Multiple Myeloma Education Network
Put this site in your favorities folder.
Shop for the Cure!
Many of the internet's most popular merchants will donate a portion of your purchases to the IMF if you enter their sites using the links on our Shop For The Cure page. You can also use the special shortcut URLs listed below:
So, Shop For The Cure by using these links to the same get great service and low prices you're used to while helping support the IMF!
Help Us Help Others...
As a non-profit organization, the IMF is completely dependent on the support of our members. Please consider showing your support by making a tax-deductible donation today. Donations in honor of a friend or family member make great gifts and are a wonderful way to celebrate a special occasion. You can donate online or by calling the IMF at (800) 452-CURE. We sincerely thank you for your support.
Tell A Friend...
The Myeloma Minute is a great way to stay abreast of the latest developments within the myeloma community. We hope you'll share this information with friends, family members and physicians and encourage them to sign up for their own copy by forwarding this message. New users can register by clicking here.